Flex Pharma (FLKS) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Flex Pharma Reports Year End 2015 Financial Results
March 8, 2016 7:01 AM ESTConference Call Scheduled Today at 8:30 a.m. ET
BOSTON--(BUSINESS WIRE)-- Click to Tweet
Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments... More
Michelle V. Stacy Joins Flex Pharma’s Board of Directors
March 7, 2016 4:01 PM EST- Former Keurig President -
BOSTON--(BUSINESS WIRE)-- Click to Tweet
Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and... More
